In the comparison of the two groups with similar age, sex, BMI, and weight-for-length SDS, serum FT4 levels were found to be lower and serum IGFBP3 levels were found to be higher in children with AD (p < 0.001 and p = 0.038, respectively). Here, IGFBP3 is linked to Alzheimer disease.